Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2020. Start Trial.
Date Value
November 13, 2026 2.324B
November 12, 2026 2.296B
November 11, 2026 2.480B
November 10, 2026 2.467B
November 09, 2026 2.598B
November 06, 2026 2.495B
November 05, 2026 2.362B
November 04, 2026 2.583B
November 03, 2026 2.491B
November 02, 2026 2.351B
October 30, 2026 2.236B
October 29, 2026 2.302B
October 28, 2026 2.291B
October 27, 2026 2.283B
October 26, 2026 2.055B
October 23, 2026 2.036B
October 22, 2026 2.064B
October 21, 2026 2.120B
October 20, 2026 2.158B
October 19, 2026 1.963B
October 16, 2026 1.779B
October 15, 2026 1.974B
October 14, 2026 1.927B
October 13, 2026 1.976B
October 12, 2026 2.100B
Date Value
October 09, 2026 2.227B
October 08, 2026 2.176B
October 07, 2026 2.102B
October 06, 2026 1.995B
October 05, 2026 2.002B
October 02, 2026 1.957B
October 01, 2026 2.073B
September 30, 2026 2.128B
September 29, 2026 2.020B
September 28, 2026 2.042B
September 25, 2026 1.991B
September 24, 2026 2.070B
September 23, 2026 2.024B
September 22, 2026 2.174B
September 21, 2026 2.171B
September 18, 2026 2.170B
September 17, 2026 2.327B
September 16, 2026 2.202B
September 15, 2026 2.300B
September 14, 2026 2.403B
September 11, 2026 2.352B
September 10, 2026 2.387B
September 09, 2026 2.514B
September 08, 2026 2.700B
September 04, 2026 3.357B

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Agenus, Inc. 487.93M
Amgen, Inc. 292.70B
Anika Therapeutics, Inc. 160.67M
BioCryst Pharmaceuticals, Inc. 2.402B
Imunon, Inc. 6.805M

Enterprise Value Related Metrics